Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T19:51:02.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The 403 Forbidden content was removed and the study details page now loads normally. This restores access to the study record and related navigation for users.
    Difference
    0.5%
    Check dated 2026-09-29T19:31:22.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record NCT02743494, replacing the expected trial details with an access-restricted screen. This indicates restricted access or a site-side block preventing display of the core content.
    Difference
    17%
    Check dated 2026-09-22T21:50:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.6 to v3.7.0, signaling an update to the page template or rendering. This appears to be a surface-level change affecting presentation, not the underlying study content.
    Difference
    0.0%
    Check dated 2026-09-15T22:05:42.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added, replacing the previous v3.6.5 to reflect a newer version of the study record metadata.
    Difference
    0.0%
    Check dated 2026-09-01T20:20:04.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    A funding reference line '2015 ( U.S. NIH Grant/Contract )' was added to the study record, indicating NIH support for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T21:47:54.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.